Qin Pan

机构：Xian Center for Disease Control and Prevention · ORCID：0000-0001-5855-4952

发表论文 145 篇 · 总被引 6640 次 · h-index 39

代表论文

• Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice (2023 · Nature Communications · 被引 163)
• Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487 (2021 · Cellular and Molecular Gastroenterology and Hepatology · 被引 75)
• Super-enhancers conserved within placental mammals maintain stem cell pluripotency (2022 · Proceedings of the National Academy of Sciences · 被引 31)
• A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors (2024 · ESMO Open · 被引 30)
• Gamma-Muricholic Acid Inhibits Nonalcoholic Steatohepatitis: Abolishment of Steatosis-Dependent Peroxidative Impairment by FXR/SHP/LXRα/FASN Signaling (2023 · Nutrients · 被引 13)
• Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis (2022 · Bioengineered · 被引 12)